Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Schuth Alexander O.
COFO and Secretary at Denali Therapeutics. Filing since 10 Dec 2018.
CIK 0001724311
Company
Date
Role
Action
Shares
Amount
Of holding
DNLI
Denali Therapeutics Inc.
1 Sep 2026
COFO and Secretary
Sold on a plan
2,768
$64.88K
1.0%
DNLI
Denali Therapeutics Inc.
11 Aug 2026
COFO and Secretary
Sold at will
2,857
$71.62K
1.0%
DNLI
Denali Therapeutics Inc.
6 Jan 2026
COFO and Secretary
Sold at will
17,218
$284.10K
5.7%
DNLI
Denali Therapeutics Inc.
12 Aug 2025
COFO and Secretary
Sold at will
2,937
$39.88K
1.2%
DNLI
Denali Therapeutics Inc.
7 Jan 2025
COFO and Secretary
Sold at will
2,907
$60.49K
1.2%
DNLI
Denali Therapeutics Inc.
6 Jan 2025
COFO and Secretary
Sold at will
12,255
$247.80K
4.7%
DNLI
Denali Therapeutics Inc.
7 Nov 2024
COFO and Secretary
Sold on a plan
15,558
$465.29K
8.0%
DNLI
Denali Therapeutics Inc.
21 Aug 2024
COFO and Secretary
Sold on a plan
2,547
$63.11K
1.4%
DNLI
Denali Therapeutics Inc.
20 Aug 2024
COFO and Secretary
Sold on a plan
5,806
$137.29K
3.1%
DNLI
Denali Therapeutics Inc.
13 Aug 2024
COFO and Secretary
Sold at will
2,272
$52.01K
1.2%
DNLI
Denali Therapeutics Inc.
14 Feb 2024
COFO and Secretary
Sold on a plan
20,128
$355.46K
9.7%
DNLI
Denali Therapeutics Inc.
13 Feb 2024
COFO and Secretary
Sold on a plan
2,716
$46.96K
1.3%
DNLI
Denali Therapeutics Inc.
5 Jan 2024
COFO and Secretary
Sold at will
9,972
$193.76K
1.8%
DNLI
Denali Therapeutics Inc.
23 Aug 2023
COFO and Secretary
Sold at will
2,522
$58.43K
0.5%
DNLI
Denali Therapeutics Inc.
21 Aug 2023
COFO and Secretary
Sold at will
2,478
$55.98K
0.5%
DNLI
Denali Therapeutics Inc.
14 Aug 2023
COFO and Secretary
Sold at will
2,772
$65.61K
0.5%
DNLI
Denali Therapeutics Inc.
10 Aug 2023
COFO and Secretary
Sold at will
2,853
$68.99K
0.5%
DNLI
Denali Therapeutics Inc.
18 Jul 2023
COFO and Secretary
Sold at will
9,702
$291.16K
1.8%
DNLI
Denali Therapeutics Inc.
17 Jul 2023
COFO and Secretary
Sold at will
10,000
$296.00K
1.9%
DNLI
Denali Therapeutics Inc.
15 May 2023
COFO and Secretary
Sold at will
10,000
$286.04K
1.9%
DNLI
Denali Therapeutics Inc.
13 Apr 2023
COFO and Secretary
Sold at will
4,898
$122.65K
0.9%
DNLI
Denali Therapeutics Inc.
12 Apr 2023
COFO and Secretary
Sold at will
5,102
$127.75K
1.0%
DNLI
Denali Therapeutics Inc.
13 Feb 2023
COFO and Secretary
Sold, plan not stated
3,497
$105.22K
0.7%
DNLI
Denali Therapeutics Inc.
8 Feb 2023
COFO and Secretary
Sold, plan not stated
1,521
$46.98K
0.3%
DNLI
Denali Therapeutics Inc.
17 Jan 2023
COFO and Secretary
Sold, plan not stated
10,000
$295.34K
2.0%
DNLI
Denali Therapeutics Inc.
5 Jan 2023
COFO and Secretary
Sold, plan not stated
2,636
$74.97K
0.5%
DNLI
Denali Therapeutics Inc.
4 Jan 2023
COFO and Secretary
Sold, plan not stated
2,912
$83.57K
1.9%
DNLI
Denali Therapeutics Inc.
19 Aug 2022
COFO and Secretary
Sold, plan not stated
2,576
$85.57K
0.5%
DNLI
Denali Therapeutics Inc.
11 Feb 2022
COO and Secretary
Sold, plan not stated
2,803
$97.21K
0.6%
DNLI
Denali Therapeutics Inc.
9 Feb 2022
COO and Secretary
Sold, plan not stated
1,423
$52.80K
0.3%
DNLI
Denali Therapeutics Inc.
5 Jan 2022
COO and Secretary
Sold, plan not stated
2,846
$127.42K
0.6%
DNLI
Denali Therapeutics Inc.
6 Dec 2021
COO and Secretary
Sold, plan not stated
10,000
$422.74K
2.2%
DNLI
Denali Therapeutics Inc.
4 Nov 2021
COO and Secretary
Sold, plan not stated
10,000
$528.40K
2.1%
DNLI
Denali Therapeutics Inc.
4 Oct 2021
COO and Secretary
Sold, plan not stated
10,000
$505.60K
2.1%
DNLI
Denali Therapeutics Inc.
7 Sep 2021
COO and Secretary
Sold, plan not stated
10,000
$555.48K
2.1%
DNLI
Denali Therapeutics Inc.
19 Aug 2021
COO and Secretary
Sold, plan not stated
2,544
$126.19K
0.5%
DNLI
Denali Therapeutics Inc.
4 Aug 2021
COO and Secretary
Sold, plan not stated
10,000
$522.23K
2.0%
DNLI
Denali Therapeutics Inc.
6 Jul 2021
COO and Secretary
Sold, plan not stated
10,000
$762.04K
2.0%
DNLI
Denali Therapeutics Inc.
4 Jun 2021
COO and Secretary
Sold, plan not stated
10,000
$645.50K
2.0%
DNLI
Denali Therapeutics Inc.
4 May 2021
COO and Secretary
Sold, plan not stated
10,000
$554.86K
1.9%
DNLI
Denali Therapeutics Inc.
5 Apr 2021
COO and Secretary
Sold, plan not stated
10,000
$560.90K
1.9%
DNLI
Denali Therapeutics Inc.
4 Mar 2021
COO and Secretary
Sold, plan not stated
10,000
$610.17K
1.8%
DNLI
Denali Therapeutics Inc.
11 Feb 2021
COO and Secretary
Sold, plan not stated
3,047
$214.34K
0.6%
DNLI
Denali Therapeutics Inc.
9 Feb 2021
COO and Secretary
Sold, plan not stated
1,468
$109.81K
0.3%
DNLI
Denali Therapeutics Inc.
4 Feb 2021
COO and Secretary
Sold, plan not stated
10,000
$678.36K
1.8%
DNLI
Denali Therapeutics Inc.
4 Jan 2021
COO and Secretary
Sold, plan not stated
70,000
$5.25M
11.4%
DNLI
Denali Therapeutics Inc.
30 Mar 2020
COO and Secretary
Sold, plan not stated
1,427
$27.81K
4.7%
DNLI
Denali Therapeutics Inc.
4 Dec 2019
COO and Secretary
Sold, plan not stated
3,121
$56.18K
10.8%
DNLI
Denali Therapeutics Inc.
4 Dec 2019
COO and Secretary
Sold, plan not stated
2,656
$47.81K
0.5%
DNLI
Denali Therapeutics Inc.
3 Dec 2019
COO and Secretary
Sold, plan not stated
1,012
$18.23K
0.2%
DNLI
Denali Therapeutics Inc.
3 Dec 2019
COO and Secretary
Sold, plan not stated
711
$12.81K
2.7%
DNLI
Denali Therapeutics Inc.
26 Nov 2019
COO and Secretary
Sold, plan not stated
229
$4.13K
0.0%
DNLI
Denali Therapeutics Inc.
25 Nov 2019
COO and Secretary
Sold, plan not stated
14,125
$254.53K
2.4%
DNLI
Denali Therapeutics Inc.
22 Nov 2019
COO and Secretary
Sold, plan not stated
646
$11.63K
0.1%
DNLI
Denali Therapeutics Inc.
9 Sep 2019
COO and Secretary
Sold, plan not stated
7,500
$136.20K
1.2%
DNLI
Denali Therapeutics Inc.
7 Aug 2019
COO and Secretary
Sold, plan not stated
7,500
$141.08K
1.2%
DNLI
Denali Therapeutics Inc.
8 Jul 2019
COO and Secretary
Sold, plan not stated
7,500
$152.14K
1.2%
DNLI
Denali Therapeutics Inc.
10 Jun 2019
COO and Secretary
Sold, plan not stated
7,500
$140.78K
1.2%
DNLI
Denali Therapeutics Inc.
13 May 2019
COO and Secretary
Sold, plan not stated
2,500
$52.73K
0.4%
DNLI
Denali Therapeutics Inc.
10 May 2019
COO and Secretary
Sold, plan not stated
2,500
$55.48K
0.4%
DNLI
Denali Therapeutics Inc.
9 May 2019
COO and Secretary
Sold, plan not stated
2,500
$57.15K
0.4%
DNLI
Denali Therapeutics Inc.
11 Apr 2019
COO and Secretary
Sold, plan not stated
2,512
$69.66K
0.4%
DNLI
Denali Therapeutics Inc.
10 Apr 2019
COO and Secretary
Sold, plan not stated
2,513
$71.02K
0.4%
DNLI
Denali Therapeutics Inc.
9 Apr 2019
COO and Secretary
Sold, plan not stated
2,475
$69.72K
0.4%
DNLI
Denali Therapeutics Inc.
13 Mar 2019
COO and Secretary
Sold, plan not stated
2,512
$60.39K
0.4%
DNLI
Denali Therapeutics Inc.
12 Mar 2019
COO and Secretary
Sold, plan not stated
2,513
$56.29K
0.4%
DNLI
Denali Therapeutics Inc.
11 Mar 2019
COO and Secretary
Sold, plan not stated
2,475
$52.64K
0.4%
DNLI
Denali Therapeutics Inc.
12 Feb 2019
COO and Secretary
Sold, plan not stated
2,500
$50.19K
0.4%
DNLI
Denali Therapeutics Inc.
11 Feb 2019
COO and Secretary
Sold, plan not stated
2,500
$47.62K
0.4%
DNLI
Denali Therapeutics Inc.
8 Feb 2019
COO and Secretary
Sold, plan not stated
2,500
$45.28K
0.4%
DNLI
Denali Therapeutics Inc.
11 Jan 2019
COO and Secretary
Sold, plan not stated
2,500
$52.00K
0.4%
DNLI
Denali Therapeutics Inc.
10 Jan 2019
COO and Secretary
Sold, plan not stated
2,500
$49.98K
0.4%
DNLI
Denali Therapeutics Inc.
9 Jan 2019
COO and Secretary
Sold, plan not stated
2,500
$50.78K
0.4%
DNLI
Denali Therapeutics Inc.
12 Dec 2018
COO and Secretary
Sold, plan not stated
2,500
$52.00K
0.4%
DNLI
Denali Therapeutics Inc.
11 Dec 2018
COO and Secretary
Sold, plan not stated
2,500
$50.55K
0.4%
DNLI
Denali Therapeutics Inc.
10 Dec 2018
COO and Secretary
Sold, plan not stated
2,500
$50.45K
0.4%
76 decisions on file.
